Webcasts on Benefit – Risk and Pharmacovigilance

In this section, you can access a series of webcasts from the EURORDIS Summer School on patient involvement in benefit risk at the European Medicines Agency, how the Pharmaceutical Risk Assessment Committee evaluates medicinal products.


Patient involvement in benefit-risk at the EMA

A slideshow presentation on the risk-benefit assessment and how the policy works through questionnaires with the EMA


Pharmacovigilance Risk Assessment Committee

A slideshow presentation on the EMA's risk assessment committee.


The Role of Patient Organisations in Pharmacovigilance

A slideshow presentation on how organisations like the Scientific Advice Working Party (SAWP) and Protocol Assistance (PA) help drugs get on the market.

The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseasesRare Disease International Bringing together patients, families and experts to share experiences in a moderated multi-language forum. RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases